The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with other published regimens in SSc patients, while maintaining a treatment effect.
Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease, Pulmonary Hypertension
The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with other published regimens in SSc patients, while maintaining a treatment effect.
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
-
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States, 15213
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States, 15261
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States, 15261
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
8 Years to 60 Years
ALL
No
Paul Szabolcs,
Paul Szabolcs, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh
2026-08-01